Form 4: Director Greg D. Carmichael Receives Encompass Health RSUs

Director Greg D. Carmichael acquired 27 restricted stock units in Encompass Health Corp via dividend reinvestment.

Summary

• Director Greg D. Carmichael was granted 27 restricted stock units (RSUs) on April 15, 2026.
• The acquisition resulted from the reinvestment of dividends paid on Encompass Health common stock.
• The transaction was valued at $0 per share as it represents a dividend equivalent credit.
• Following this transaction, the director's total beneficial ownership stands at 18,686 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing with no impact on the company's operational or financial outlook.

Positives

• Reflects ongoing alignment of director interests with shareholders through equity-based compensation.
• Demonstrates consistent dividend payment policy by the issuer.

Future Outlook

Not applicable as this is a routine disclosure of director equity holdings.

Industry Context

StockSavvy.ai notes that this filing is a standard administrative disclosure for healthcare services companies, reflecting routine equity maintenance for board members rather than a strategic shift.

Comparison to Industry Standards

• The practice of crediting dividend equivalents to RSU accounts is standard corporate governance practice among S&P 500 and mid-cap healthcare firms.
• The transaction size is immaterial relative to the total market capitalization of Encompass Health.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation adjustment.

Key Dates

Keywords

Encompass Health, EHC, Form 4, Insider Transaction, Director Compensation, Dividend Reinvestment